5 Reasons Why Buying This 6%-Yielding Dividend Stock Could Be a Brilliant MoveThe Motley Fool • 03/18/24
Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff ConcernsSeeking Alpha • 03/18/24
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?The Motley Fool • 03/15/24
European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal DiseaseBusiness Wire • 03/13/24
Pfizer Inc. (PFE) Leerink Partners Global Biopharma Conference 2024 - (Transcript)Seeking Alpha • 03/12/24
What To Know About Adcetris—Pfizer's Cancer Drug Extended Survival For Patients With Common LymphomaForbes • 03/12/24
Pfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)Business Wire • 03/12/24